| Literature DB >> 33028289 |
Jian-Ning Sun1, Yu Zhang1, Ye Zhang1, Jia-Ming Zhang2, Xiang-Yang Chen3, Shuo Feng4.
Abstract
BACKGROUND: The incidence of fractures around the femoral prosthesis among patients undergoing hip arthroplasty is increasing and has become the third leading cause of hip revision. While numerous methods for the surgical treatment of periprosthetic femoral fractures (PFFs) have been proposed, only few reports have examined the long-term efficacy of surgical treatment. This study aims to examine the mid-and long-term efficacy of surgical treatment among patients with Vancouver B2 and B3 PFFs.Entities:
Keywords: Hip arthroplasty; Periprosthetic femoral fractures; Vancouver B2/B3
Mesh:
Year: 2020 PMID: 33028289 PMCID: PMC7539422 DOI: 10.1186/s12893-020-00891-9
Source DB: PubMed Journal: BMC Surg ISSN: 1471-2482 Impact factor: 2.102
Vancouver classification of fractures, and time interval between index arthroplasty and fracture
| Vancouver Category | Primary-Replacement | Revision Group | Intraoperative fracture Group | Time interval between index arthroplasty and fracture | Total |
|---|---|---|---|---|---|
| B2 | 44(64%) | 10(14%) | 15(22%) | 78.6 ± 25.3 (range,14–133) | 69 |
| B3 | 8(58%) | 3(21%) | 3(21%) | 88.3 ± 32.7 (range,4–121) | 14 |
Fig. 1Cemented stem, fall, B2 fracture. Exchange to a modular stem. After 5 years of follow-up, no subsidence or loosening of the implant
Fig. 2Uncemented stem, traffic accident, B2 fracture. Exchange to a nonmodular stem. After 1 years of follow-up, fracture unhealed
Baseline characteristics of the study patients
| Classification | B2 | B3 | Total |
|---|---|---|---|
| Number | 69(83%) | 14(17%) | 83(100%) |
| Gender (female/male) | 38/31 | 9/5 | |
| Age (years) | 63.4 ± 9.1 | 66.4 ± 11.3 | 63.9 ± 9.5 |
| Stem before revision | |||
| uncemented | 47(57%) | 7(8%) | 54(65%) |
| cemented stem | 22(27%) | 7(8%) | 29(35%) |
| Injury mechanism | |||
| mild trauma | 59(71%) | 5(6%) | 64(77%) |
| immense trauma | 6(7%) | 7(8%) | 13(15%) |
| unknown cause | 4(5%) | 2(3%) | 6(8%) |
| Comorbidities (principal) | |||
| Cardiovascular diseases | 27(33%) | 7(8%) | 34(41%) |
| Respiratory diseases | 15(18%) | 3(4%) | 18(22%) |
| Endocrine diseases | 9(11%) | 2(3%) | 11(14%) |
| Other | 7(8%) | 2(3%) | 9(11%) |
| ASA1 | 5(6%) | 0 | 5(6%) |
| ASA2 | 12(14%) | 2(3%) | 14(17%) |
| ASA3 | 32(39%) | 7(8%) | 39(47%) |
| ASA4 | 20(24%) | 5(6%) | 25(30%) |
| SF-36 (Pre) | 28.6 ± 10.4 | 31.0 ± 12.3 | 29.0 ± 10.7 |
Fig. 3Uncemented stem, traffic accident, B3 fracture. Treated with ORIF + cortical strut allograft. In the third year after surgery, the prosthesis was significantly loosened and the patient received a second revision operation
Serious complications which occurred during 10 year follow-up
| complication | Number | Treatment |
|---|---|---|
| Dislocation | 13 | recurrent dislocation revised to constrained liner |
| Aseptic loosening | 8 | |
| Infection | 2 | |
| Nonunion | 2 | |
Fig. 4Kaplan-Meier survival curve for patients with B2 and B3 type PFFs after revision surgery
Fig. 5Kaplan-Meier survival curve (revision for any cause) of implants for patients with B2 and B3 type PFFs after revision surgery
Fig. 6SF-36 score curve of patients with B2 and B3 fractures
Data of patients who died within one year after operation
| Number | Time (month) | Cause of death |
|---|---|---|
| 1 | 2 | Multiple organ failure |
| 2 | 7 | Cerebral infarction |
| 3 | 8 | pulmonary embolism |
| 4 | 8 | Unknown cause of death |
| 5 | 9 | Renal failure |
| 6 | 10 | Multiple organ failure |
| 7 | 12 | pulmonary infection |